A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

Clinical trial NCT00078598 · UNKNOWN

Trial details

NCT number: NCT00078598
Sponsor: Corixa Corporation
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2004-04-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.